Calorie restriction and reversal of type 2 diabetes

References

• Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–110.
   PubMed Web of Science ®Google Scholar
• Lillioja S, Mott DM, Howard BV, et al. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross sectional studies in Pima Indians. New England J Med. 1988;318:1217–1225.
   PubMed Web of Science ®Google Scholar
• Rudenski AS, Hadden DR, Atkinson AB, et al. Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabetic Med. 1988;5:36–41.
   PubMed Web of Science ®Google Scholar
• Franco M, Bilal U, Ordunez P, et al. Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. Brit Med J. 2013;346:f1515.
   PubMed Web of Science ®Google Scholar
• Gregg EW, Cheng YJ, Narayan KM, et al. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med. 2007;45:348–352.
   PubMed Web of Science ®Google Scholar
• Taylor R. Pathogenesis of Type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia. 2008;51:1781–1789.
   PubMed Web of Science ®Google Scholar
• Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002;87:3023–3028.
   PubMed Web of Science ®Google Scholar
• Petersen KF, Dufour S, Befroy D, et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005;54:603–608.
   PubMed Web of Science ®Google Scholar
• Ravikumar B, Gerrard J, Dalla Man C, et al. Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content. Diabetes. 2008;57:2288–2295.
   PubMed Web of Science ®Google Scholar
• Petersen KF, Dufour S, Savage DB, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A. 2007;104:12587–12594.
   PubMed Web of Science ®Google Scholar
• Sevastianova K, Santos A, Kotronen A, et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr. 2012;96:427–434.
   Web of Science ®Google Scholar
• Sattar N, McConnachie A, Ford I, et al. Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes. 2007;56:984–991.
   PubMed Web of Science ®Google Scholar
• Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–2514.
   PubMed Web of Science ®Google Scholar
• Malandrucco I, Pasqualetti P, Giordani I, et al. Very-low-calorie diet: a quick therapeutic tool to improve beta cell function in morbidly obese patients with type 2 diabetes. Am J Clin Nutr. 2012;95:609–613.
   PubMed Web of Science ®Google Scholar
• Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55:2025–2031.
   PubMed Web of Science ®Google Scholar
• Carey PE, Halliday J, Snaar JEM, et al. Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. Am J Physiol. 2003;284:E286–294.
   Web of Science ®Google Scholar
• Macauley M, Smith FE, Thelwall PE, et al. Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and Type 2 diabetes. Clin Sci (Lond). 2015;128:707–713.
   PubMed Web of Science ®Google Scholar
• Taylor R. Insulin resistance and type 2 diabetes. Diabetes. 2012;61:778–779.
   PubMed Web of Science ®Google Scholar
• Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Very low calorie diet and 6 months of weight stability in Type 2 daibetes: pathophysiological changes in responders and nonresponders. Diabetes Care. 2016;39:158–165.
   PubMed Web of Science ®Google Scholar
• Bruning JC, Michael MD, Winnay JN, et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998;2:559–569.
   PubMed Web of Science ®Google Scholar
• Savage DB, Zhai L, Ravikumar B, et al. A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice. PLoS Med. 2008;5:e27.
   PubMed Web of Science ®Google Scholar
• Petersen KF, Dufour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350:664–671.
   PubMed Web of Science ®Google Scholar
• Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia. 2007;50:113–120.
   PubMed Web of Science ®Google Scholar
• Brehm A, Krssak M, Schmid AI, et al. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes. 2006;55:136–140.
   PubMed Web of Science ®Google Scholar
• Lim EL, Hollingsworth KG, Smith FE, et al. Inhibition of lipolysis in Type 2 diabetes normalizes glucose disposal without change in muscle glycogen synthesis rates. Clin Sci (Lond). 2011;121:169–177.
   PubMed Web of Science ®Google Scholar
• Lim EL, Hollingsworth KG, Thelwall PE, et al. Measuring the acute effect of insulin infusion on ATP turnover rate in human skeletal muscle using phosphorus-31 magnetic resonance saturation transfer spectroscopy. NMR Biomed. 2010;23:952–957.
   PubMed Web of Science ®Google Scholar
• Lee Y, Hirose H, Ohneda M, et al. B-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-B-Cell relationships. Proc Natl Acad Sci USA. 1994;91:10878–10882.
   PubMed Web of Science ®Google Scholar
• Moffitt JH, Fielding BA, Evershed R, et al. Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia. 2005;48:1819–1829.
   PubMed Web of Science ®Google Scholar
• Pinnick K, Neville M, Clark A, et al. Reversibility of metabolic and morphological changes associated with chronic exposure of pancreatic islet beta-cells to fatty acids. J Cell Biochem. 2010;109:683–692.
   PubMed Web of Science ®Google Scholar
• Pinnick KE, Collins SC, Londos C, et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity. 2008;16:522–530.
   PubMed Web of Science ®Google Scholar
• Lalloyer F, Vandewalle B, Percevault F, et al. Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes. 2006;55:1605–1613.
   PubMed Web of Science ®Google Scholar
• Ohneda M, Inman LR, Unger RH. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia. 1995;38:173–179.
   PubMed Web of Science ®Google Scholar
• Macauley M, Percival K, Thelwall PE, et al. Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One. 2015;10:e0126825.
   Web of Science ®Google Scholar
• Rahier J, Guiot Y, Goebbels RM, et al. Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab. 2008;Suppl 10:32–42.
   Web of Science ®Google Scholar
• Talchai C, Xuan S, Lin Hua V, et al. Accili D pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell. 2012;150:1223–1234.
   PubMed Web of Science ®Google Scholar
• White MG, Marshall HL, Rigby R, et al. Expression of mesenchymal and alpha-cell phenotypic markers in islet beta-cells in recently diagnosed diabetes. Diabetes Care. 2013;36:3818–3820.
   PubMed Web of Science ®Google Scholar
• Cinti F, Bouchi R, Kim-Muller JY, et al. Evidence of beta-cell dedifferentiation in human type 2 diabetes. J Clin Endocrinol Metab. 2016;101:1044–1054.
   PubMed Web of Science ®Google Scholar
• Pories WJ, MacDonald KG Jr., Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55:582S–585S.
   PubMed Web of Science ®Google Scholar
• Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Jama. 2008;299:316–323.
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care. 2009;32:514–520.
   PubMed Web of Science ®Google Scholar
• Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–749.
   PubMed Web of Science ®Google Scholar
• Holst JJ. Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1. Diabetes. 2011;60:2203–2205.
   PubMed Web of Science ®Google Scholar
• Gibney ER, Murgatroyd P, Wright A, et al. Measurement of total energy expenditure in grossly obese women: comparison of the bicarbonate-urea method with whole-body calorimetry and free-living doubly labelled water. Int J Obes Relat Metab Disord. 2003;27:641–647.
   PubMed Web of Science ®Google Scholar
• Colles SL, Dixon JB, Marks P, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84:304–311.
   PubMed Web of Science ®Google Scholar
• Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36:1047–1055.
   PubMed Web of Science ®Google Scholar
• Hadden DR. Obstetric and diabetic care for pregnancy in diabetic women: 10 years outcome analysis, 1985-1995. Diabetic Med. 2001;18:546–553.
   PubMed Web of Science ®Google Scholar
• Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007;133:496–506.
   PubMed Web of Science ®Google Scholar
• Lee Y, Lingvay I, Szczepaniak LS, et al. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond). 2010;34:396–400.
   PubMed Web of Science ®Google Scholar
• Steven S, Carey PE, Small PK, et al. Reversal of Type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short- and long-duration diabetes. Diabet Med. 2015;32:47–53.
   PubMed Web of Science ®Google Scholar
• Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20:1245–1250.
   PubMed Web of Science ®Google Scholar
• Al-Mrabeh A, Hollingsworth KG, Steven S, et al. Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity. Diabetologia. 2016;59:1753–1759.
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–2693.
   PubMed Web of Science ®Google Scholar
• Peters C, Steven S, Taylor R. Reversal of type 2 diabetes by weight loss despite presence of macro-and micro-vascular complications. In: Draznin B, editor. Diabetes case studies: real problems, practical solutions. Alexandria (VA): American Diabetes Association; 2015.
   Google Scholar
• Steven S, Lim E, Taylor R. Population response to information on reversibility of type 2 diabetes. Diabetic Med. 2013;30:e135–138.
   PubMed Web of Science ®Google Scholar
• Vaag A, Lund SS. Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention? Appl Physiol Nutr Metab. 2007;32:912–920.
   PubMed Web of Science ®Google Scholar
• Östenson C-G, Efendic S. Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans. Diabetes Obes Metab. 2007;9 Suppl 2:180–186.
   PubMed Web of Science ®Google Scholar
• Turner RC, Holman RR, Matthews D, et al. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979;28:1086–1096.
   PubMed Web of Science ®Google Scholar
• Hinnouho G-M, Czernichow S, Dugravot A, et al. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care. 2013;36:2294–2300.
   PubMed Web of Science ®Google Scholar
• Hollenbeck CB, Chen YD, Reaven GM. A comparison of the relative effects of obesity and non-insulin dependent diabetes mellitus on in vivo insulin stimulated glucose utilization. Diabetes. 1984;33:622–626.
   PubMed Web of Science ®Google Scholar
• Juhl CB, Bradley U, Holst JJ, et al. Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and Type 2 diabetes: action LADA 8. Diabet Med. 2014;31:941–945.
   PubMed Web of Science ®Google Scholar
• McCarthy ST, Harris E, Turner RC. Glucose control of basal insulin secretion in diabetes. Diabetologia. 1977;13:93–97.
   PubMed Web of Science ®Google Scholar
• Turner RC, McCarthy ST, Holman RR, et al. Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. Br Med J. 1976;1:1252–1254.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Chen YD, Hollenbeck CB, et al. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab. 1993;76:44–48.
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–1596.
   PubMed Web of Science ®Google Scholar
• Bi Y, Tong GY, Yang HJ, et al. The beneficial effect of metformin on beta-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes. Diabetes Metab Res Rev. 2013;29:664–672.
   PubMed Web of Science ®Google Scholar
• Ito H, Ishida H, Takeuchi Y, et al. Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus. Nutr Metab (Lond). 2010;7:83.
   PubMed Web of Science ®Google Scholar
• Taylor R, Holman R. Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clin Sci. 2015;128:405–410.
   PubMed Web of Science ®Google Scholar
• UKPDS. UK prospective diabetes study (UKPDS). VIII. Study design, progress and performance. Diabetologia. 1991;34:877–890.
   PubMed Web of Science ®Google Scholar
• Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790–797.
   PubMed Web of Science ®Google Scholar
• Schwarz J-M, Linfoot P, Dare D, et al. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr. 2003;77:43–50.
   PubMed Web of Science ®Google Scholar
• Shibata M, Kihara Y, Taguchi M, et al. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2007;30:2940–2944.
   PubMed Web of Science ®Google Scholar
• Perseghin G, Lattuada G, De Cobelli F, et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care. 2007;30:683–688.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30:1212–1218.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Angulo P, Lymp J, et al. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatol. 2005;41:64–71.
   PubMed Web of Science ®Google Scholar
• Giannini C, Weiss R, Cali A, et al. Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes. 2012;61:606–614.
   PubMed Web of Science ®Google Scholar
• Cali AM, Man CD, Cobelli C, et al. Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabetes Care. 2009;32:456–461.
   PubMed Web of Science ®Google Scholar
• Festa A, Williams K, D’Agostino R Jr., et al. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes. 2006;55:1114–1120.
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Nannipieri M, Williams K, et al. Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes. 2004;53:160–165.
   PubMed Web of Science ®Google Scholar
• Tabak AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373:2215–2221.
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Williams K, Festa A, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004;53:2623–2632.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Cull CA, Stratton IM, et al. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med. 1998;15:297–303.
   PubMed Web of Science ®Google Scholar
• Camastra S, Manco M, Mari A, et al. Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care. 2007;30:1002–1004.
   PubMed Web of Science ®Google Scholar
• Steven S, Hollingsworth KG, Small P, et al. Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes. Diabetes Care. 2016;39:158–165.
   PubMed Web of Science ®Google Scholar